Delves into all aspects of R&D and manufacturing of all oral solid dose (OSD) forms. Tracks industry trends. Relays latest applied research relevant to OSDs. Provides “how to” information for the latest techniques in formulation/excipients, tablet manufacturing, capsule filling and other aspects of the process—including logistics like supply-chain management.
One element that is sometimes overlooked is data integrity from in vivo testing. Specifically, is data garnered from stressed species valid and/or reliable? Is it reproducible?
read more
Much like the winemakers who learned to harness pressure rather than fear it, OSD manufacturers are leveraging advances in manufacturing processes, formulation science, excipients and packaging ...
read more
As the industry looks toward 2026, oral solid dosage forms remain firmly at the center of pharmaceutical and nutraceutical innovation — but the forces shaping the market are becoming more complex and ...
read more
Tablet delamination and capping are the most common tablet defects, causing costly production disruptions and lost batches.
read more
Just as traveling salesmen once had to balance opportunity, risk and proximity to their customers, today’s pharmaceutical suppliers face similar pressures as they pursue the dream of the world’s ...
read more
Conventional drying will remain useful, but it does not have to set the limits of formulation. Lyophilization offers a way to reduce risk, protect value and build products that are ready today — and ...
read more
Driven by persistent supply chain disruptions, shifting trade dynamics, evolving customer expectations and the accelerating growth of the nutraceutical sector, the pharma ecosystem is rewiring where —...
read more
Although not a routine manufacturing step, granulation plays a central role in determining the quality, consistency and performance of modern OSD products. This article explores how granulation can ...
read more
Scaling up a tablet coating process from work performed with a small-scale unit to a full-scale production plant raises critical questions: Which controls and product attributes must remain unchanged,...
read more
Ensuring the quality of finished products not only requires in-house quality control processes but also a robust supplier qualification process. Establishing a supplier qualification program is one of...
read more
The FDA deadline to meet nitrosamine control guidance is upon us. Here’s a review of past nitrosamine-related regulatory actions — and lessons learned.
read more
More than an ambition or just another formulation strategy, patient-centric drug design is the future of pharma. As emerging technologies make gathering and implementing user feedback simpler than ...
read more
While colors are up for interpretation, science generally is not. Health misinformation has always existed, but took centerstage during the pandemic when social media quickly became a powerful tool ...
read more
The first federal ban on a synthetic color due to the outdated Delaney Clause has inked a line in the sand — and crossing it could push the industry past the threshold of science-driven formulation ...
read more
Speed-to-market, efficiency, flexibility, quality. These aren’t just buzzwords — they’re critical goals every pharma manufacturer must achieve to bring new therapies to patients. The challenge lies in...
read more